Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:12 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 524602 | NSE: BANDARAM

Bandaram Pharma Packtech Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹47.70Undervalued by 108.30%vs CMP ₹22.90

P/E (105.0) × ROE (7.9%) × BV (₹7.12) × DY (0.44%)

₹21.72Fairly Valued by 5.15%vs CMP ₹22.90
MoS: -5.4% (Negative)Confidence: 56/100 (Moderate)Models: 1 Under, 6 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹50.1131%Under (+118.8%)
Graham NumberEarnings₹6.5819%Over (-71.3%)
Net Asset ValueAssets₹7.1310%Over (-68.9%)
EV/EBITDAEnterprise₹10.8013%Over (-52.8%)
Earnings YieldEarnings₹2.7010%Over (-88.2%)
ROCE CapitalReturns₹9.5010%Over (-58.5%)
Revenue MultipleRevenue₹20.598%Over (-10.1%)
Consensus (7 models)₹21.72100%Fairly Valued
Key Drivers: P/E of 105 makes PE-ROE unreliable — asset/earnings models are better benchmarks. | Wide model spread (₹3–₹50) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 5.1%

*Investments are subject to market risks

Investment Snapshot

43
Bandaram Pharma Packtech Ltd scores 43/100 (Weak)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health37/100 · Weak
ROCE 7.7% WeakROE 7.9% AverageD/E 4.61 High debtInterest Coverage 0.0x RiskyProfitable 3/5 years Mixed
Smart Money35/100 · Weak
Promoter decreased by 12.38% Caution
Earnings Quality55/100 · Moderate
OPM expanding (3% → 8%) ImprovingWorking capital: 165 days Capital intensive
Quarterly Momentum50/100 · Moderate
Revenue (4Q): +8% YoY GrowingProfit (4Q): -43% YoY Declining
Industry Rank30/100 · Weak
P/E 105.0 vs industry 25.3 Premium to peersROCE 7.7% vs industry 9.3% AverageROE 7.9% vs industry 134.8% Below peers

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:12 am

Market Cap 41.1 Cr.
Current Price 22.9
Intrinsic Value₹21.72
High / Low 51.6/22.0
Stock P/E105
Book Value 7.12
Dividend Yield0.44 %
ROCE7.67 %
ROE7.94 %
Face Value 10.0
PEG Ratio20.75

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Bandaram Pharma Packtech Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Bandaram Pharma Packtech Ltd 41.1 Cr. 22.9 51.6/22.0105 7.120.44 %7.67 %7.94 % 10.0
Gratex Industries Ltd 5.26 Cr. 17.4 26.2/14.258.4 12.20.00 %3.85 %2.52 % 10.0
Ganga Papers India Ltd 74.0 Cr. 68.6 111/68.651.0 29.00.00 %6.44 %5.19 % 10.0
Genus Paper & Boards Ltd 266 Cr. 10.4 22.0/8.6528.3 20.30.00 %4.73 %0.61 % 1.00
Cella Space Ltd 27.1 Cr. 13.4 19.3/9.5528.2 10.30.00 %10.7 %% 10.0
Industry Average694.36 Cr69.4125.25107.280.86%9.32%134.80%6.50

All Competitor Stocks of Bandaram Pharma Packtech Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 5.4010.065.877.367.3613.4311.377.1110.008.498.1013.7214.84
Expenses 4.659.695.346.896.8912.7010.836.029.347.957.4713.2713.84
Operating Profit 0.750.370.530.470.470.730.541.090.660.540.630.451.00
OPM % 13.89%3.68%9.03%6.39%6.39%5.44%4.75%15.33%6.60%6.36%7.78%3.28%6.74%
Other Income 0.020.170.000.000.000.030.000.000.000.090.000.010.00
Interest 0.140.130.280.170.170.320.210.260.24-0.100.460.250.33
Depreciation 0.190.100.180.180.180.190.150.150.150.530.130.140.14
Profit before tax 0.440.310.070.120.120.250.180.680.270.200.040.070.53
Tax % 0.00%0.00%0.00%0.00%0.00%24.00%0.00%0.00%103.70%25.00%25.00%28.57%33.96%
Net Profit 0.430.310.070.120.120.190.180.67-0.020.150.020.060.35
EPS in Rs 0.360.260.060.100.100.160.150.56-0.010.120.020.020.11

Last Updated: March 3, 2026, 11:56 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 12:35 am

MetricMar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 0.0018.7334.0836.9645.15
Expenses 0.0117.5831.2634.1342.53
Operating Profit -0.011.152.822.832.62
OPM % 6.14%8.27%7.66%5.80%
Other Income 0.000.190.030.090.10
Interest 0.000.430.930.990.94
Depreciation 0.000.590.730.610.94
Profit before tax -0.010.321.191.320.84
Tax % 0.00%21.88%20.17%24.24%
Net Profit -0.010.260.950.990.58
EPS in Rs -0.010.120.790.820.27
Dividend Payout % 0.00%21.43%12.63%12.12%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2022-20232023-20242024-2025
YoY Net Profit Growth (%)2700.00%265.38%4.21%
Change in YoY Net Profit Growth (%)0.00%-2434.62%-261.17%

Bandaram Pharma Packtech Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 3 years from 2022-2023 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:%
TTM:-15%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:366%
TTM:36%
Stock Price CAGR
10 Years:68%
5 Years:%
3 Years:%
1 Year:-24%
Return on Equity
10 Years:%
5 Years:%
3 Years:7%
Last Year:8%

Last Updated: September 5, 2025, 2:36 pm

Balance Sheet

Last Updated: March 3, 2026, 12:36 am

MonthMar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 7.063.0012.0012.0012.00
Reserves -0.060.080.280.650.80
Borrowings -0.0014.2012.2017.1521.89
Other Liabilities 0.482.907.589.125.67
Total Liabilities 7.4820.1832.0638.9240.36
Fixed Assets 2.875.034.483.953.69
CWIP -0.00-0.00-0.00-0.00-0.00
Investments 2.09-0.001.401.401.40
Other Assets 2.5215.1526.1833.5735.27
Total Assets 7.4820.1832.0638.9240.36

Reserves and Borrowings Chart

Cash Flow

MonthMar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + -1.10-4.13-4.93
Cash from Investing Activity + -5.30-1.58-0.08
Cash from Financing Activity + 4.475.595.09
Net Cash Flow -1.93-0.110.08
Free Cash Flow -3.89-4.31-5.01
CFO/OP -96%-139%-163%

Free Cash Flow

MonthMar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-0.01-13.05-9.38-14.32

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 129.01155.51185.27
Inventory Days
Days Payable
Cash Conversion Cycle 129.01155.51185.27
Working Capital Days 147.13147.59165.22
ROCE %5.69%9.10%7.67%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%62.62%
DIIs 0.04%0.04%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.00%0.00%
Public 24.96%24.96%24.99%24.99%25.00%25.00%24.99%25.00%24.99%24.99%25.00%37.37%
No. of Shareholders 4,1434,1514,2734,2624,3374,4254,6344,7674,8274,8894,9555,095

Shareholding Pattern Chart

No. of Shareholders

Bandaram Pharma Packtech Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23
FaceValue 10.0010.0010.00
Basic EPS (Rs.) 0.830.810.47
Diluted EPS (Rs.) 0.830.810.47
Cash EPS (Rs.) 1.341.402.81
Book Value[Excl.RevalReserv]/Share (Rs.) 10.5410.2317.11
Book Value[Incl.RevalReserv]/Share (Rs.) 10.5410.2317.11
Revenue From Operations / Share (Rs.) 30.8028.4062.44
PBDIT / Share (Rs.) 2.432.384.48
PBIT / Share (Rs.) 1.921.772.53
PBT / Share (Rs.) 1.100.981.09
Net Profit / Share (Rs.) 0.820.780.85
NP After MI And SOA / Share (Rs.) 0.450.430.47
PBDIT Margin (%) 7.888.367.16
PBIT Margin (%) 6.236.224.04
PBT Margin (%) 3.563.481.73
Net Profit Margin (%) 2.682.781.37
NP After MI And SOA Margin (%) 1.471.520.75
Return on Networth / Equity (%) 4.324.244.59
Return on Capital Employeed (%) 9.2510.695.90
Return On Assets (%) 1.401.620.70
Long Term Debt / Equity (X) 0.710.382.48
Total Debt / Equity (X) 1.360.994.61
Asset Turnover Ratio (%) 1.041.300.00
Current Ratio (X) 2.202.132.05
Quick Ratio (X) 1.591.601.68
Inventory Turnover Ratio (X) 4.946.560.00
Dividend Payout Ratio (NP) (%) 43.900.0084.68
Dividend Payout Ratio (CP) (%) 20.700.0016.51
Earning Retention Ratio (%) 56.100.0015.32
Cash Earning Retention Ratio (%) 79.300.0083.49
Interest Coverage Ratio (X) 2.953.053.11
Interest Coverage Ratio (Post Tax) (X) 2.012.011.60
Enterprise Value (Cr.) 75.8559.4237.98
EV / Net Operating Revenue (X) 2.051.742.03
EV / EBITDA (X) 26.0120.8528.28
MarketCap / Net Operating Revenue (X) 1.511.301.17
Retention Ratios (%) 56.090.0015.31
Price / BV (X) 4.403.627.10
Price / Net Operating Revenue (X) 1.511.301.17
EarningsYield 0.010.010.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Bandaram Pharma Packtech Ltd. is a Public Limited Listed company incorporated on 05/08/1993 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L93090KA1993PLC159827 and registration number is 159827. Currently company belongs to the Industry of Paper & Paper Products. Company's Total Operating Revenue is Rs. 12.23 Cr. and Equity Capital is Rs. 12.00 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Paper & Paper Products601,5th Floor, Oxford Towers, Opp to Leela Palace Hotel, Bengaluru Karnataka 560008Contact not found
Management
NamePosition Held
Mr. B Deepak ReddyChairman & Managing Director
Mr. Nadella Srinivasula Kalki Aakarsh RajWhole Time Director
Mr. B Premsai ReddyNon Executive Director
Ms. B SathyavathiNon Executive Director
Mr. B Suryaprakasa RaoIndependent Director
Ms. Priyanka AgarwalIndependent Director
Mr. Suman MalluIndependent Director
Ms. Mounika PammiIndependent Director

FAQ

What is the intrinsic value of Bandaram Pharma Packtech Ltd and is it undervalued?

As of 14 April 2026, Bandaram Pharma Packtech Ltd's intrinsic value is ₹21.72, which is 5.15% lower than the current market price of ₹22.90, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (7.94 %), book value (₹7.12), dividend yield (0.44 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Bandaram Pharma Packtech Ltd?

Bandaram Pharma Packtech Ltd is trading at ₹22.90 as of 14 April 2026, with a FY2026-2027 high of ₹51.6 and low of ₹22.0. The stock is currently near its 52-week low. Market cap stands at ₹41.1 Cr..

How does Bandaram Pharma Packtech Ltd's P/E ratio compare to its industry?

Bandaram Pharma Packtech Ltd has a P/E ratio of 105, which is above the industry average of 25.25. This significantly elevated P/E suggests the market expects strong future growth, or the stock may be overpriced relative to current earnings.

Is Bandaram Pharma Packtech Ltd financially healthy?

Key indicators for Bandaram Pharma Packtech Ltd: ROCE of 7.67 % is on the lower side compared to the industry average of 9.32%; ROE of 7.94 % is below ideal levels (industry average: 134.80%). Dividend yield is 0.44 %.

Is Bandaram Pharma Packtech Ltd profitable and how is the profit trend?

Bandaram Pharma Packtech Ltd reported a net profit of ₹1 Cr in Mar 2025 on revenue of ₹37 Cr. Compared to ₹0 Cr in Mar 2022, the net profit shows an improving trend.

Does Bandaram Pharma Packtech Ltd pay dividends?

Bandaram Pharma Packtech Ltd has a dividend yield of 0.44 % at the current price of ₹22.90. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Bandaram Pharma Packtech Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports